Risk factors of chronic kidney disease in HIV-infected patients

Philippe Flandre1, Pascal Pugliese, Lise Cuzin

  • 1INSERM UMR-S 943 Pierre & Marie Curie University, Paris, France.

Insights

Chronic kidney disease (CKD) is a significant risk for HIV-1 patients, particularly those exposed to specific antiretroviral drugs like tenofovir and abacavir. Close renal function monitoring is crucial for these individuals.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) poses a significant health challenge in patients with human immunodeficiency virus type 1 (HIV-1) infection.
  • Identifying risk factors for CKD is crucial for proactive management and improved patient outcomes in HIV-1 care.

Purpose of the Study:

  • To determine the risk factors associated with the development of chronic kidney disease (CKD) in a large cohort of HIV-1-infected patients.
  • To investigate the impact of antiretroviral therapies (ARVs) and other clinical factors on CKD incidence.

Main Methods:

  • A prospective cohort study involving 7378 HIV-1-infected patients across seven French reference centers.
  • CKD was defined as two consecutive estimated glomerular filtration rate (eGFR) measurements ≤60 ml/min/1.73 m² over at least 3 months.
  • Cox's proportional hazards model with delayed entry was utilized to identify predictive factors for CKD development.

Main Results:

  • The incidence of CKD was 349 cases out of 7378 patients between 1993 and 2006.
  • Acute kidney injury (HR=2.40) and hypertension (HR=2.39) were strongly associated with increased CKD risk.
  • Exposure to specific ARVs, including recent indinavir (HR=2.03), tenofovir (HR=1.55), and abacavir (HR=1.37), increased CKD risk. Past tenofovir exposure showed a higher risk (HR=2.23).

Conclusions:

  • CKD is not uncommon in HIV-1-infected patients and is linked to exposure to certain ARVs.
  • Abacavir, indinavir, and tenofovir were identified as ARVs associated with a higher risk of CKD.
  • Enhanced renal function monitoring is recommended for HIV-1 patients exposed to these specific antiretroviral medications.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...